Wall Street analyst estimates for Alto Ingredients, Inc. (ALTO): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Alto Ingredients, Inc., operating within the United States, specializes in the production and commercialization of both specialty alcohols and various essential ingredients. Its operations are structured into three distinct segments: Marketing and Distribution, Pekin Production, and Other Production. The company's diverse product portfolio includes a range of specialty alcohols, which find applications across the health, home, and beauty sectors.
Valuation Ratios
| P/E Ratio | 5.68 |
| Price / Book | 1.13 |
| EV / EBITDA | 5.19 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.62B | $1.63B | $1.52B | $1.42B | $897.0M | $1.21B | $1.34B | $1.22B | $965.3M | $917.9M |
| Cost of Revenue | $1.57B | $1.63B | $1.53B | $1.43B | $844.2M | $1.14B | $1.36B | $1.21B | $955.5M | $891.1M |
| Gross Profit | $51.8M | $5.9M | -$15.2M | -$9.9M | $52.9M | $67.8M | -$27.6M | $15.7M | $9.7M | $26.8M |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $28.3M | $31.5M | $36.4M | $35.5M | $32.0M | $29.2M | $28.1M | $32.7M | $29.7M | $27.2M |
| Operating Expenses | $28.3M | $31.5M | $36.4M | $64.7M | $43.0M | $27.7M | $33.8M | $39.5M | $61.4M | $19.7M |
| Operating Income | $23.5M | -$25.6M | -$51.5M | -$74.7M | $9.9M | $40.1M | -$61.4M | -$23.8M | -$51.7M | $7.1M |
| EBITDA | $57.9M | $13.2M | -$10.5M | -$33.2M | $30.9M | $74.4M | -$12.8M | $2.6M | -$26.8M | $48.7M |
| Interest Expense | $22.4M | $12.9M | $17.1M | $20.2M | $17.9M | $3.6M | $1.8M | $7.4M | $7.6M | $10.8M |
| Pre-tax Income | $545000 | -$38.4M | -$68.5M | -$101.3M | -$17.3M | $47.6M | -$39.7M | -$27.9M | -$58.8M | $12.7M |
| Income Tax | -$981000 | -$321000 | -$562000 | -$20000 | -$17000 | $1.5M | $1.9M | $97000 | $173000 | -$621000 |
| Net Income | $1.4M | -$35.0M | -$60.3M | -$88.9M | -$15.1M | $46.1M | -$41.6M | -$28.0M | -$59.0M | $13.3M |
| EPS | $0.00 | $-0.82 | $-1.39 | $-2.14 | $-0.29 | $0.62 | $-0.58 | $-0.40 | $-0.82 | $0.16 |
| EPS (Diluted) | $0.00 | $-0.82 | $-1.39 | $-2.14 | $-0.29 | $0.61 | $-0.58 | $-0.40 | $-0.82 | $0.16 |
| Shares Outstanding (Diluted) | $42.3M | $42.7M | $43.4M | $47.4M | $58.6M | $72.2M | $71.9M | $73.3M | $73.5M | $75.7M |
Price
| Price | $4.02 |
| Market Cap | $311M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AMTX · AXTA · FF · GEVO · GPRE · REX
Explore sector: Basic Materials · Chemicals - Specialty
More sections of ALTO: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks